Company CVAbout Novelix Pharmaceuticals Ltd 
Novelix Pharmaceuticals Ltd
Micro Cap
Retailing
Novelix Pharmaceuticals Limited was initially incorporated as 'Trimurthi Securities Limited' on December 13, 1994. The name of the Company was changed from Trimurthi Securities Limited to Trimurthi Drugs & Pharmaceuticals Limited. Also, the name of the Company was changed to Trimurthi Drugs & Pharmaceuticals Limited and again to Trimurthi Limited in May, 2016. The Company has altered the name to Novelix Pharmaceuticals Limited in 2025.
Company Coordinates
Company Details
4-4-231/1/2/ABC Inderbagh, Sultan Bazar Hyderabad Telangana : 500095
Registrar Details
Venture Capital & Corporate Investments Ltd , 12-10-167,, MIG- 167,, Bharat Nagar Colony, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR 8.10 Cr
Number of Shares
81 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
19-Feb-2013
81
8.10
1350000
10
Conversion of Warrants
19-Feb-2013
81
8.10
1350000
10
Conversion of Warrants
04-Oct-2010
67.5
6.75
-60750000
10
Consolidation of Shares
04-Oct-2010
67.5
6.75
-60750000
10
Consolidation of Shares
15-Oct-2009
6.75
6.75
60750000
1
Stock Split
15-Oct-2009
6.75
6.75
60750000
1
Stock Split
11-Oct-2007
67.5
6.75
750000
10
Allotment of Equity To Others
11-Oct-2007
67.5
6.75
750000
10
Allotment of Equity To Others
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Srinidhi Fine-chemicals Llp (34.07%)
Highest Public shareholder
Mallela Venkatramna Reddy (8.52%)
Individual Investors Holdings
42.69%
Board of Directors
Management
Designation
Remuneration
Arvind Kumar Bhangadia
Non Executive Director
15.0 lacs
Natwarlal Ramgopal Modani
Independent Director
0
Sagar Rajendra Karwa
Independent Director
0
Monam Kapoor
Independent Director
0
ADITYA BHANGADIA
Managing Director
0
Ravi Bhangadia
Chairman & Wholetime Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchase of Securities
0.36572
0%
Purchase of Securities
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Interest
0.57
15.98%
Interest
Interest
Stock DNARevenue and Profits:
Net Sales:
36 Cr
(Quarterly Results - Sep 2025)
Net Profit:
1 Cr
Retailing
INR 110 Cr (Micro Cap)
116.00
33
0.00%
-0.06
3.71%
4.31
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
